In Nigeria, as many as half of women who need breast cancer surgery are turning it down. In Mexico, women may wait up to six months to find out if they have breast cancer once they suspect it. These are just some of the findings of newly published findings in the April 1 edition of The Breast, a report by the Breast Health Global Initiative, operated by the Fred Hutchinson Cancer Center in partnership with Susan G. Komen for the Cure. Consensus statements and 11 research papers were based on projects presented last June at the Breast Health Global Initiative Summit last June in Chicago. An executive summary of the consensus statements was published simultaneously in the April 1 edition of The Lancet Oncology. More information is located here.
A big part of our work is reaching out to women who are considered “medically underserved,” that is, the poor or uninsured, under-insured; women who don’t know about breast health or who have no idea how to access the healthcare system (with few resources) if something is wrong. Susan G. Komen for the Cure and Komen Affiliates have funded thousands of community grants aimed at these women over the years, and we’re delighted today to report on a new grant, from the KeyBank Foundation in Cleveland, that will really help this work along.
KeyBank is granting $1 million over four years to train almost 500 people as Komen Lay Health Advisors. Lay health advisors work one-on-one with women in their communities to educate them about their breast health, provide information, refer them to health care resources, support them during health care visits, and more.
This Lay Health Advisors program will be established first in Northeast Ohio, where Komen’s Northeast Ohio Affiliate is already familiar with the benefits of one-on-one connections through programs the Affiliate is already funding locally. Over four years, the KeyBank Foundation funding will help establish similar Lay Health Advisor programs in 16 other cities currently served by KeyBank and Komen Affiliates. Also on tap: regional breast cancer summits to educate and raise awareness about breast cancer issues locally.
KeyCorp president and CEO Beth Mooney and Ambassador Nancy G. Brinker announced the grant in Cleveland this afternoon. Mooney noted that breast cancer’s impact is especially devastating for women of color, who are more likely to die from breast cancer, and for poor or uninsured women who lack access to health care resources. “Our investment in this innovative program reflects our corporate diversity vision and is just one way we give back to the communities where the people of Key live and work,” Mooney said. Brinker echoed the sentiment, saying the grant will help Komen reach women who might otherwise not be reached.
This partnership is yet another example of how our partners are helping to meet important needs around the world.
Thanks to all of our partners for making this work possible!
Read more about it in our full press release.
More than 1,000 Susan G. Komen for the Cure breast cancer advocates, grantees, corporate partners and volunteers converged in Fort Worth, Texas, for the 2011 Susan G. Komen Leadership Conference this past weekend. It was two days of learning, sharing and re-committing to the community outreach, research and advocacy that only Komen does in thousands of communities and 50 countries worldwide. A highlight of the weekend was a visit from philanthropist David Rubenstein, who shared his unique insights on charitable giving:
We’re grateful for donors like David, and for our more than 200 corporate partners, hundreds of grantees and of course, our Komen Affiliates who make our work possible in your neighborhood. We heard about how our research is moving the needle on metastatic and aggressive disease; and how our community programs helped screen some 700,000 women last year. Our advocacy is helping to keep breast cancer programs intact for low-income and uninsured women across the country; and our global work is opening doors for women in countries where cancer still brings stigma and shame.
We were so happy to have members of our family in town to share best-in-class knowledge and practices, celebrating our accomplishments in the breast cancer movement and inspire each other to keep moving forward.
We are truly the boldest community united against breast cancer.
Be sure to check out some pictures from the Leadership Conference below and on Flickr.
March 17, 2011 Breast Cancer, Breast Cancer News, Global, Komen Advocacy, Komen Leadership News, Komen News, Mission
We are all devastated by the ongoing crisis in Japan. More than 70 nations have opened their hearts and wallets to assist with food, medicine and dollars. But humanitarian assistance takes many forms, and the global cancer community has a vital role to play to help address a looming cancer crisis caused by the nuclear accidents in Japan.
You can help us in our efforts to avert this potential cancer crisis. As leader of the world’s largest breast cancer organization, I am calling on global cancer leaders to develop a cancer action plan – today — for Japan. I need your support to show that we are all unified for the people of Japan, and for those who may be affected by nuclear accidents today and into the future, wherever they may live.
I know the devastation that these accidents can cause. I served on the National Cancer Advisory Board after the Chernobyl accident, horrified to see an aftermath that produced the largest group of cancers ever. It’s been 25 years since Chernobyl, but exposure to fallout may be responsible for thyroid cancers that are still occurring in people who lived there.
We must act now and we are. Susan G. Komen for the Cure will convene a panel of global experts to immediately begin addressing the future cancer risks generated from this incident and draft a plan of action.
Here’s where you can help. We are asking all of you — our vast network of global friends and supporters — to sign a petition calling for the release of all information regarding the accident and the potential effects of migrating radiation. As Japan works to contain the current crisis and provide for the immediate needs of its citizens, we urge the government to partner with the global cancer community to help protect the long term public health of people in Japan and around the world.
Please show your support by signing our petition at the link below.SIGN OUR PETITION
The New York Times recently featured a story raising concerns about the “unrealistic optimism” that many cancer patients have who sign up for early Phase I or II clinical trials. Some doctors and ethicists worried that too many volunteers have their hopes too high that the drug or treatment being tested will conquer their cancer. But George Sledge, M.D., a member of our Scientific Advisory Board, isn’t all that concerned about the volunteers’ high hopes. In fact, as he writes in the current edition of the ASCO Connection, he’s proud of them.
Check out Dr. Sledge’s article here.